ニュース

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to ...
Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...
There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or ...
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...
Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.
GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...
Scientists at Jiangnan University in China recently found that there is a specific gut microbe known as Bacteroides vulgatus, ...
Weight Loss RX Reviews today published their groundbreaking "2025 American Compounded Semaglutide Consumer Insight Report" – ...
In patients with type 2 diabetes (T2D), treatment with oral semaglutide demonstrated a modest but significant reduction in ...
For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.
Pritty Vishy has been exploring different things with her body, including cosmetic surgery. She shared a video undergoing ...